Citation Impact
Citing Papers
Review article: the global emergence of Helicobacter pylori antibiotic resistance
2015
Expanded therapeutic potential in activity space of next-generation 5-nitroimidazole antimicrobials with broad structural diversity
2013 StandoutNobel
Antiparasitic Drug Nitazoxanide Inhibits the Pyruvate Oxidoreductases of Helicobacter pylori , Selected Anaerobic Bacteria and Parasites, and Campylobacter jejuni
2006
Management of Helicobacter pylori infection—the Maastricht V/Florence Consensus Report
2016 Standout
Management of Helicobacter pylori infection—the Maastricht IV/ Florence Consensus Report
2012 Standout
Origin of Antibiotics and Antibiotic Resistance, and Their Impacts on Drug Development: A Narrative Review
2023 Standout
Genes required for mycobacterial growth defined by high density mutagenesis
2003 Standout
Click chemistry-facilitated comprehensive identification of proteins adducted by antimicrobial 5-nitroimidazoles for discovery of alternative drug targets against giardiasis
2020 StandoutNobel
Changes in the intestine microbial, digestion and immunity of Litopenaeus vannamei in response to dietary resistant starch
2019 Standout
Nitazoxanide
2007
Heterogeneity ofHelicobacter pylori caggenotypes in experimentally infected mice
2001
Characterization of the genes rdxA and frxA involved in metronidazole resistance in Helicobacter pylori
2003
pH‐Dependent Protein Profiles of Helicobacter pylori Analyzed by Two‐Dimensional Gels
2000
Identification of natural inhibitors of Entamoeba histolytica cysteine synthase from microbial secondary metabolites
2015 StandoutNobel
Reduction of polynitroaromatic compounds: the bacterial nitroreductases
2008
The Role of the Ferric Uptake Regulator (Fur) in Regulation of Helicobacter pylori Iron Uptake
2002
Mechanism of IS200/IS605 Family DNA Transposases: Activation and Transposon-Directed Target Site Selection
2008
A painful peripheral neuropathy in the rat produced by the chemotherapeutic drug, paclitaxel
2001 Standout
Ecological Hypothesis of Dentin and Root Caries
2016 Standout
The spectrum of latent tuberculosis: rethinking the biology and intervention strategies
2009 Standout
Emergence of recombinant strains ofHelicobacter pyloriduring human infection
1999
Role of the thioredoxin system and the thiol-peroxidases Tpx and Bcp in mediating resistance to oxidative and nitrosative stress in Helicobacter pylori
2003
A change in PBP1 is involved in amoxicillin resistance of clinical isolates of Helicobacter pylori
2002
Metabolism of nitro drugs metronidazole and nitazoxanide in Giardia lamblia: characterization of a novel nitroreductase (GlNR2)
2013
Determinants of stunting in Indonesian children: evidence from a cross-sectional survey indicate a prominent role for the water, sanitation and hygiene sector in stunting reduction
2016 Standout
Optimal therapy for Helicobacter pylori infections
2011
Analysis of metronidazole, clarithromycin and tetracycline resistance of Helicobacter pylori isolates from Korea
2001
In vivo antiprotozoan effects of garlic (Allium sativum) and ginger (Zingiber officinale) extracts on experimentally infected mice with Blastocystis spp.
2015
The Physiology and Metabolism of the Human Gastric Pathogen Helicobacter pylori
1998
Structural and Mechanistic Studies of Escherichia coli Nitroreductase with the Antibiotic Nitrofurazone
2005
Evidence for Induction of Integron-Based Antibiotic Resistance by the SOS Response in a Clinical Setting
2012
Helicobacter pylori isolates recovered from gastric biopsies of patients with gastro‐duodenal pathologies in Cameroon: current status of antibiogram
2008
Is the molecular basis of metronidazole resistance in microaerophilic organisms understood?
2002
Impact of clarithromycin resistance and CYP2C19 genetic polymorphism on treatment efficacy of Helicobacter pylori infection with lansoprazole- or rabeprazole-based triple therapy in Japan
2003
Targeting bacterial membrane function: an underexploited mechanism for treating persistent infections
2010
Mutations in Helicobacter pylori rdxA gene sequences may not contribute to metronidazole resistance
2003
Environmental factors influencing the development and spread of antibiotic resistance
2017 Standout
Enzymatic activation of nitro-aryl fluorogens in live bacterial cells for enzymatic turnover-activated localization microscopy
2012 StandoutNobel
Helicobacter pylori eradication and gastric ulcer healing — comparison of three pantoprazole‐based triple therapies
2003
Newer antibacterial drugs for a new century
2010
The primary transcriptome of the major human pathogen Helicobacter pylori
2010 StandoutNature
Characterization and function analysis of Hsp60 and Hsp10 under different acute stresses in black tiger shrimp, Penaeus monodon
2015
How were new medicines discovered?
2011 Standout
Prevalence of Antibiotic Resistance in Helicobacter pylori: A Systematic Review and Meta-analysis in World Health Organization Regions
2018 Standout
Next-generation DNA sequencing
2008 Standout
Influence of diet on the gut microbiome and implications for human health
2017 Standout
The thioredoxin antioxidant system
2013 Standout
H pylori antibiotic resistance: prevalence, importance, and advances in testing
2004 Standout
Differential gene expression in a Bacteroides fragilis metronidazole-resistant mutant
2004
Nanomaterial-based therapeutics for antibiotic-resistant bacterial infections
2020 Standout
A Brief History of the Antibiotic Era: Lessons Learned and Challenges for the Future
2010 Standout
Photodynamic therapy: a new antimicrobial approach to infectious disease?
2004 Standout
Eradication of Helicobacter pylori by 7‐Day Triple‐Therapy Regimens Combining Pantoprazole with Clarithromycin, Metronidazole, or Amoxicillin in Patients with Peptic Ulcer Disease: Results of Two Double‐Blind, Randomized Studies
2003
Antimicrobial reactive oxygen and nitrogen species: concepts and controversies
2004 Standout
Epidemiology and mechanism of antibiotic resistance in
1998
A review and meta‐analysis of the impact of intestinal worms on child growth and nutrition
2008
Untapped potential: exploiting fungi in bioremediation of hazardous chemicals
2011 Standout
Comparison of three different second‐line quadruple therapies including bismuth subcitrate in Turkish patients with non‐ulcer dyspepsia who failed to eradicate Helicobacter pylori with a 14‐day standard first‐line therapy
2007
NikR-mediated regulation of Helicobacter pylori acid adaptation
2004
Determining antibiotic resistance in Helicobacter pylori
2002
Molecular testing for antibiotic resistance in Helicobacter pylori
2002
Acetogenesis and the Wood–Ljungdahl pathway of CO2 fixation
2008 Standout
Drug resistance pattern and clonality in H. pylori strains
2009
The i genome sequence: G genome sequence: Genetic factors for long life in the gastric mucosa
1997
Current concepts in the management of Helicobacter pylori infection: the Maastricht III Consensus Report
2006 Standout
Mutation discovery in bacterial genomes: metronidazole resistance in Helicobacter pylori
2005
Pharmaceutical and therapeutic Potentials of essential oils and their individual volatile constituents: a review
2007 Standout
Production of the RdxA protein in metronidazole-susceptible and -resistant isolates of Helicobacter pylori cultured from treated mice
2002
The physiology and metabolism of Campylobacter jejuni and Helicobacter pylori
2001
Pyruvate:ferredoxin oxidoreductase and thioredoxin reductase are involved in 5-nitroimidazole activation while flavin metabolism is linked to 5-nitroimidazole resistance in Giardia lamblia
2011
Hydrogen Peroxide: A Signaling Messenger
2006 Standout
Chemical Constituents and Pharmacological Activities of Garlic (Allium sativum L.): A Review
2020 Standout
Metabolic Pathways for Cytotoxic End Product Formation from Glutamate- and Aspartate-Containing Peptides by Porphyromonas gingivalis
2000
Applications of the Ninhydrin Reaction for Analysis of Amino Acids, Peptides, and Proteins to Agricultural and Biomedical Sciences
2004 Standout
Current Therapeutics, Their Problems, and Sulfur-Containing-Amino-Acid Metabolism as a Novel Target against Infections by “Amitochondriate” Protozoan Parasites
2007
Antisense RNA Modulation of Alkyl Hydroperoxide Reductase Levels in Helicobacter pylori Correlates with Organic Peroxide Toxicity but Not Infectivity
2007
Basis for the Management of Drug-Resistant Helicobacter pylori Infection
2004
Growth Phase-Dependent Response ofHelicobacter pylorito Iron Starvation
2003
Nitazoxanide for the empiric treatment of pediatric infectious diarrhea
2012
Molecular basis of metronidazole resistance in pathogenic bacteria and protozoa
1999
Interspecies Transfer of Antibiotic Resistance between Helicobacter pylori and Helicobacter acinonychis
2001
Roles of FrxA and RdxA Nitroreductases of Helicobacter pylori in Susceptibility and Resistance to Metronidazole
2001
Helicobacter pyloriDetection and Antimicrobial Susceptibility Testing
2007
Nitazoxanide, a broad-spectrum thiazolide anti-infective agent for the treatment of gastrointestinal infections
2006
Antimicrobial Susceptibility Testing of Helicobacter pylori in a Large Multicenter Trial: the MACH 2 Study
1999
Helicobacter pylori eradication in Western Australia using novel quadruple therapy combinations
2012
Antimicrobial Susceptibility and Resistance Patterns among Helicobacter pylori Strains from The Gambia, West Africa
2012
High-Level β-Lactam Resistance Associated with Acquired Multidrug Resistance in Helicobacter pylori
2003
Essential Thioredoxin-Dependent Peroxiredoxin System from Helicobacter pylori : Genetic and Kinetic Characterization
2001
Nanomaterials and nanoparticles: Sources and toxicity
2007 Standout
Antimicrobial resistance induced by genetic changes.
2010
Synthesis and Electrochemistry of 2-Ethenyl and 2-Ethanyl Derivatives of 5-Nitroimidazole and Antimicrobial Activity against Giardia lamblia
2009 StandoutNobel
Heat shock protein 90 mediates macrophage activation by Taxol and bacterial lipopolysaccharide
1999
Bacterial Resistance to β-Lactam Antibiotics: Compelling Opportunism, Compelling Opportunity
2005 Standout
Impaired Parasite Attachment as Fitness Cost of Metronidazole Resistance in Giardia lamblia
2011
GENETIC MUTATIONS AFFECTING THE FIRST LINE ERADICATION THERAPY OF Helicobacter pylori-INFECTED EGYPTIAN PATIENTS
2016
Click Chemistry-Facilitated Structural Diversification of Nitrothiazoles, Nitrofurans, and Nitropyrroles Enhances Antimicrobial Activity against Giardia lamblia
2017 StandoutNobel
Programmed DNA destruction by miniature CRISPR-Cas14 enzymes
2018 StandoutScienceNobel
Nitroreductase (GlNR1) increases susceptibility of Giardia lamblia and Escherichia coli to nitro drugs
2011
Amixicile, a Novel Inhibitor of Pyruvate:Ferredoxin Oxidoreductase, Shows Efficacy against Clostridium difficile in a Mouse Infection Model
2012
Cefiderocol: A New Cephalosporin Stratagem Against Multidrug-Resistant Gram-Negative Bacteria
2021
Pathogenesis ofHelicobacter pyloriInfection
2006 Standout
Helicobacter pyloriPhysiology Predicted from Genomic Comparison of Two Strains
1999
Alterations in Penicillin-Binding Protein 1A Confer Resistance to β-Lactam Antibiotics in Helicobacter pylori
2002
Binding of Actinobacillus pleuropneumoniae to Phosphatidylethanolamine
2003
Helicobacter pylori Primary Resistance to Metronidazole and Clarithromycin in Brazil
2002
Bacterial Antibiotic Resistance: The Most Critical Pathogens
2021 Standout
Acid-Adaptive Genes of Helicobacter pylori
2003
Emergence of Tetracycline Resistance in Helicobacter pylori : Multiple Mutational Changes in 16S Ribosomal DNA and Other Genetic Loci
2002
Mutations in the 16S rRNA Genes ofHelicobacter pyloriMediate Resistance to Tetracycline
2002
Acid-Responsive Gene Induction of Ammonia-Producing Enzymes in Helicobacter pylori Is Mediated via a Metal-Responsive Repressor Cascade
2004
Modified Sequential Therapy Regimen versus Conventional Triple Therapy forHelicobacter pyloriEradication in Duodenal Ulcer Patients in China: A Multicenter Clinical Comparative Study
2012
Biofilm-Related Infections: Bridging the Gap between Clinical Management and Fundamental Aspects of Recalcitrance toward Antibiotics
2014 Standout
Mutations of the Helicobacter pylori Genes rdxA and pbp1 Cause Resistance against Metronidazole and Amoxicillin
2001
Organocatalytic Reactions Enabled by N-Heterocyclic Carbenes
2015 Standout
Helicobacter pylori Virulence and Genetic Geography
1999 StandoutScience
Systematic Identification of Selective Essential Genes in Helicobacter pylori by Genome Prioritization and Allelic Replacement Mutagenesis
2001
Metabolism and Genetics of Helicobacter pylori : the Genome Era
1999
TheHelicobacter pyloriplasticity region locusjhp0947âjhp0949is associated with duodenal ulcer disease and interleukin-12 production in monocyte cells
2004
Drug Targets and Mechanisms of Resistance in the Anaerobic Protozoa
2001
Biological Degradation of 2,4,6-Trinitrotoluene
2001
NikR Mediates Nickel-Responsive Transcriptional Induction of Urease Expression inHelicobacter pylori
2002
Identification of a nitroimidazo-oxazine-specific protein involved in PA-824 resistance in Mycobacterium tuberculosis
2005
Antibiotic susceptibility of Helicobacter pylori in Germany: stable primary resistance from 1995 to 2000
2002
Bacteroides: the Good, the Bad, and the Nitty-Gritty
2007 Standout
Pyruvate Ferredoxin Oxidoreductase and Its Radical Intermediate
2003
The Helicobacter pylori Homologue of the Ferric Uptake Regulator Is Involved in Acid Resistance
2002
Giardia , Entamoeba , and Trichomonas Enzymes Activate Metronidazole (Nitroreductases) and Inactivate Metronidazole (Nitroimidazole Reductases)
2008
Differentiation of Metronidazole-Sensitive and -Resistant Clinical Isolates of Helicobacter pylori by Immunoblotting with Antisera to the RdxA Protein
2001
Superoxide Dismutase-Deficient Mutants of Helicobacter pylori Are Hypersensitive to Oxidative Stress and Defective in Host Colonization
2001
Why Metronidazole Is Active against both Bacteria and Parasites
1999
Works of Avery Goodwin being referenced
Characterization of the NAD(P)H oxidase and metronidazole reductase activities of the RdxA nitroreductase of Helicobacter pylori
2009
Metronidazole resistance in Helicobacter pylori is due to null mutations in a gene (rdxA) that encodes an oxygen‐insensitive NADPH nitroreductase
1998
Metabolic activities of metronidazole-sensitive and -resistant strains of Helicobacter pylori: repression of pyruvate oxidoreductase and expression of isocitrate lyase activity correlate with resistance
1996
Metronidazole Activation Is Mutagenic and Causes DNA Fragmentation in Helicobacter pylori and in Escherichia coli Containing a Cloned H. pylori rdxA + (Nitroreductase) Gene
2000
Enzymes Associated with Reductive Activation and Action of Nitazoxanide, Nitrofurans, and Metronidazole in Helicobacter pylori
2002
Characterization of an Acidic-pH-Inducible Stress Protein (hsp70), a Putative Sulfatide Binding Adhesin, fromHelicobacter pylori
1998
US Food and Drug Administration (FDA): Benefit-Risk Considerations for Cefiderocol (Fetroja®)
2020
Insertion of Mini-IS 605 and Deletion of Adjacent Sequences in the Nitroreductase ( rdxA ) Gene Cause Metronidazole Resistance in Helicobacter pylori NCTC11637
1999